AU2002308347A1 - Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides - Google Patents
Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosidesInfo
- Publication number
- AU2002308347A1 AU2002308347A1 AU2002308347A AU2002308347A AU2002308347A1 AU 2002308347 A1 AU2002308347 A1 AU 2002308347A1 AU 2002308347 A AU2002308347 A AU 2002308347A AU 2002308347 A AU2002308347 A AU 2002308347A AU 2002308347 A1 AU2002308347 A1 AU 2002308347A1
- Authority
- AU
- Australia
- Prior art keywords
- tumours
- treatment
- immunotherapeutic combinations
- gangliosides
- overexpress
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000002270 gangliosides Chemical class 0.000 title 1
- 230000001024 immunotherapeutic Effects 0.000 title 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU84/2001 | 2001-04-06 | ||
| CU2001008420010084A CU23007A1 (en) | 2001-04-06 | 2001-04-06 | IMMUNOTHERAPEUTIC COMBINATIONS FOR THE TREATMENT IMMUNOTHERAPEUTIC COMBINATIONS FOR THE TREATMENT OF TUMORS THAT OVER-EXPRESS GANGLIOSIDES TO OF TUMORS THAT OVER-EXPRESS GANGLOSIDES |
| PCT/CU2002/000002 WO2002081661A2 (en) | 2001-04-06 | 2002-04-08 | Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002308347A1 true AU2002308347A1 (en) | 2003-04-10 |
| AU2002308347B2 AU2002308347B2 (en) | 2006-09-14 |
Family
ID=40291118
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002308348A Ceased AU2002308348B2 (en) | 2001-04-06 | 2002-04-08 | Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours |
| AU2002308347A Ceased AU2002308347B2 (en) | 2001-04-06 | 2002-04-08 | Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| AU2007231687A Expired - Fee Related AU2007231687B2 (en) | 2001-04-06 | 2007-10-26 | Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumors |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002308348A Ceased AU2002308348B2 (en) | 2001-04-06 | 2002-04-08 | Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2007231687A Expired - Fee Related AU2007231687B2 (en) | 2001-04-06 | 2007-10-26 | Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumors |
Country Status (37)
| Country | Link |
|---|---|
| US (3) | US20050069535A1 (en) |
| EP (3) | EP1798243B1 (en) |
| JP (2) | JP4366080B2 (en) |
| KR (3) | KR100863509B1 (en) |
| CN (3) | CN101054417B (en) |
| AR (2) | AR033123A1 (en) |
| AT (3) | ATE477279T1 (en) |
| AU (3) | AU2002308348B2 (en) |
| BG (2) | BG66293B1 (en) |
| BR (3) | BR0208675A (en) |
| CA (2) | CA2443372C (en) |
| CU (1) | CU23007A1 (en) |
| CZ (2) | CZ304424B6 (en) |
| DE (2) | DE60228561D1 (en) |
| DK (2) | DK1384726T3 (en) |
| EA (2) | EA006936B1 (en) |
| EC (2) | ECSP034788A (en) |
| ES (2) | ES2296986T3 (en) |
| HK (3) | HK1066818A1 (en) |
| HR (2) | HRP20030805B1 (en) |
| HU (2) | HU228106B1 (en) |
| IL (2) | IL158246A0 (en) |
| IS (2) | IS2701B (en) |
| MX (2) | MXPA03008738A (en) |
| MY (3) | MY145703A (en) |
| NO (2) | NO331533B1 (en) |
| NZ (2) | NZ528599A (en) |
| PE (1) | PE20020972A1 (en) |
| PL (2) | PL371770A1 (en) |
| PT (2) | PT1384726E (en) |
| SG (1) | SG161737A1 (en) |
| SI (2) | SI1384726T1 (en) |
| SK (2) | SK287783B6 (en) |
| UA (3) | UA75393C2 (en) |
| UY (2) | UY27243A1 (en) |
| WO (2) | WO2002081496A2 (en) |
| ZA (2) | ZA200307585B (en) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7297336B2 (en) * | 2003-09-12 | 2007-11-20 | Baxter International Inc. | Factor IXa specific antibodies displaying factor VIIIa like activity |
| RU2396088C2 (en) * | 2005-02-04 | 2010-08-10 | СУРВАК АпС | Survivin peptide vaccine |
| FI20055398A0 (en) * | 2005-07-08 | 2005-07-08 | Suomen Punainen Risti Veripalv | Method for evaluating cell populations |
| CA2618796C (en) * | 2005-08-11 | 2018-01-02 | Arpi Matossian-Rogers | Peptides for treatment and diagnosis of autoimmune disease |
| WO2007024535A2 (en) | 2005-08-19 | 2007-03-01 | Wyeth | Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8-associated disorders |
| ITFI20060163A1 (en) * | 2006-06-29 | 2006-09-28 | Menarini Internat Operations Luxembourg Sa | PHARMACEUTICAL COMPOSITION CONTAINING A MONOCLONAL ANTI-IDIOTIC ANTI-CA-125 AND ALUMINUM ANTIBODY |
| TWI434855B (en) | 2006-11-21 | 2014-04-21 | Hoffmann La Roche | Conjugate and its use as a standard in an immunoassay |
| US20110286937A1 (en) * | 2008-02-22 | 2011-11-24 | Gifu University | Synthetic glycolipid-containing liposome |
| EP2166085A1 (en) | 2008-07-16 | 2010-03-24 | Suomen Punainen Risti Veripalvelu | Divalent modified cells |
| TWI516501B (en) | 2008-09-12 | 2016-01-11 | 禮納特神經系統科學公司 | Pcsk9 antagonists |
| NZ612647A (en) | 2009-03-10 | 2015-03-27 | Biogen Idec Inc | Anti-bcma antibodies |
| JP6132548B2 (en) * | 2009-04-01 | 2017-05-24 | ジェネンテック， インコーポレイテッド | Anti-FcRH5 antibodies and immunoconjugates and methods of use |
| CU23736A1 (en) | 2009-05-04 | 2011-11-15 | Centro Inmunologia Molecular | ANTIBODIES RECOGNIZING SULFATIDES AND SULFATED PROTEOGLYCANS AND THEIR USE |
| WO2011026242A1 (en) * | 2009-09-03 | 2011-03-10 | Vancouver Biotech Ltd. | Monoclonal antibodies against gonadotropin-releasing hormone receptor |
| AU2012205663B2 (en) * | 2011-01-10 | 2017-02-02 | Emory University | Antibodies directed against influenza |
| CU24070B1 (en) | 2011-12-27 | 2015-01-29 | Ct De Inmunología Molecular | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TUMORS EXPRESSING REGF AND GM3 N-GLYCOLLATED GANGLIOSIDS (NEUGCGM3) |
| EP2641916A1 (en) * | 2012-03-23 | 2013-09-25 | Centre National de la Recherche Scientifique (C.N.R.S) | Novel antibodies anti-sPLA2-IIA and uses thereof |
| WO2013186719A1 (en) | 2012-06-15 | 2013-12-19 | Pfizer Inc. | Improved antagonist antibodies against gdf-8 and uses therefor |
| TWI725931B (en) | 2013-06-24 | 2021-05-01 | 美商建南德克公司 | Anti-fcrh5 antibodies |
| PE20210107A1 (en) | 2013-12-17 | 2021-01-19 | Genentech Inc | ANTI-CD3 ANTIBODIES AND METHODS OF USE |
| JP2017512759A (en) * | 2014-04-10 | 2017-05-25 | オービーアイ ファーマ インコーポレイテッド | Antibody, hybridoma producing said antibody, pharmaceutical composition containing said antibody and use thereof |
| TWI715587B (en) | 2015-05-28 | 2021-01-11 | 美商安可美德藥物股份有限公司 | Tigit-binding agents and uses thereof |
| IL256079B2 (en) | 2015-06-16 | 2024-01-01 | Genentech Inc | Humanized and affinity matured antibodies to fcrh5 and methods of use |
| WO2018017864A2 (en) * | 2016-07-20 | 2018-01-25 | Oncomed Pharmaceuticals, Inc. | Pvrig-binding agents and uses thereof |
| RU2765410C2 (en) | 2016-11-30 | 2022-01-28 | Онкомед Фармасьютикалс, Инк. | Methods for treating cancer, including tigit-binding agents |
| CU20170173A7 (en) * | 2017-12-27 | 2019-11-04 | Ct Inmunologia Molecular | NANO-PARTICLES CONTAINING GM3 GANGLIOSIDE AS IMMUNOMODULATORS |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2754206B2 (en) * | 1987-11-17 | 1998-05-20 | メクト株式会社 | Monoclonal antibody that recognizes α2 → 3 linkage |
| US6051225A (en) * | 1988-10-19 | 2000-04-18 | The Dow Chemical Company | Family of high affinity, modified antibodies for cancer treatment |
| DE69327620T2 (en) * | 1992-08-18 | 2000-08-03 | Immunologia Molecular Ciudad D | Monoclonal antibodies to the epidermal growth factor receptor, cells and methods for their preparation and compositions containing them |
| JPH07101999A (en) * | 1993-10-06 | 1995-04-18 | Hagiwara Yoshihide | Amino acid sequence of anti-idiotype antibody to anti-cancer human monoclonal antibody and dna base sequence coding for the same |
| EP0657471B1 (en) * | 1993-12-09 | 2001-10-24 | Centro de Inmunologia Molecular | Anti ganglioside monoclonal antibodies and their use in the specific active immunotherapy of malignant tumours |
| CU22702A1 (en) * | 1997-10-21 | 2001-07-31 | Centro Inmunologia Molecular | ANTI - IDIOTIPO MONOCLONAL ANTIBODIES, THEIR USE IN THE ACTIVE IMMUNOTHERAPY OF MALIGNUM TUMORS, HYBRIDOMA THAT PRODUCES THEM AND COMPOSITIONS THAT CONTAIN THEM |
| US6063379A (en) * | 1993-12-09 | 2000-05-16 | Centro De Inmunologia Molecular | Anti-idiotypic monoclonal antibodies and compositions including the anti-idiotypic monoclonal antibodies |
| CU22420A1 (en) * | 1993-12-29 | 1996-01-31 | Centro Inmunologia Molecular | Vaccine composition for the development of an answer against gangliosides and glycolilades and its use for cancer treatment |
| US6149921A (en) * | 1993-12-29 | 2000-11-21 | Centro De Inmunologia Molecular | Vaccine compositions for eliciting an immune response against N-acetylated gangliosides and their use for cancer treatment |
| CU22615A1 (en) * | 1994-06-30 | 2000-02-10 | Centro Inmunologia Molecular | PROCEDURE FOR OBTAINING LESS IMMUNOGENIC MONOCLONAL ANTIBODIES. MONOCLONAL ANTIBODIES OBTAINED |
| CU22731A1 (en) * | 1998-02-05 | 2002-02-28 | Centro Inmunologia Molecular | MONOCLONAL ANTIBODY THAT RECOGNIZES THE SYNLICAL OLIGOSACÁRIDO SYNALIC N´GLICOLILADO-GALACTOSA-GLUCOSA (NGCNEU-GAL-GLU) IN MALIGN TUMORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| US7442776B2 (en) * | 1999-10-08 | 2008-10-28 | Young David S F | Cancerous disease modifying antibodies |
-
2001
- 2001-04-06 CU CU2001008420010084A patent/CU23007A1/en unknown
-
2002
- 2002-04-05 AR ARP020101264A patent/AR033123A1/en not_active Application Discontinuation
- 2002-04-05 MY MYPI20081190A patent/MY145703A/en unknown
- 2002-04-05 UY UY27243A patent/UY27243A1/en unknown
- 2002-04-05 AR ARP020101263A patent/AR033122A1/en unknown
- 2002-04-05 MY MYPI20021239A patent/MY157372A/en unknown
- 2002-04-05 MY MYPI20021228A patent/MY137078A/en unknown
- 2002-04-05 UY UY27242A patent/UY27242A1/en not_active Application Discontinuation
- 2002-04-08 NZ NZ528599A patent/NZ528599A/en not_active IP Right Cessation
- 2002-04-08 PT PT02759751T patent/PT1384726E/en unknown
- 2002-04-08 EP EP06076643A patent/EP1798243B1/en not_active Expired - Lifetime
- 2002-04-08 KR KR1020037012938A patent/KR100863509B1/en not_active IP Right Cessation
- 2002-04-08 CN CN2007101021039A patent/CN101054417B/en not_active Expired - Fee Related
- 2002-04-08 AT AT06076643T patent/ATE477279T1/en not_active IP Right Cessation
- 2002-04-08 MX MXPA03008738A patent/MXPA03008738A/en not_active Application Discontinuation
- 2002-04-08 JP JP2002580025A patent/JP4366080B2/en not_active Expired - Fee Related
- 2002-04-08 HU HU0401355A patent/HU228106B1/en not_active IP Right Cessation
- 2002-04-08 IL IL15824602A patent/IL158246A0/en unknown
- 2002-04-08 WO PCT/CU2002/000003 patent/WO2002081496A2/en active Application Filing
- 2002-04-08 SK SK1216-2003A patent/SK287783B6/en not_active IP Right Cessation
- 2002-04-08 ES ES02759752T patent/ES2296986T3/en not_active Expired - Lifetime
- 2002-04-08 SK SK1226-2003A patent/SK287914B6/en not_active IP Right Cessation
- 2002-04-08 KR KR1020037012969A patent/KR100946168B1/en not_active IP Right Cessation
- 2002-04-08 DE DE60228561T patent/DE60228561D1/en not_active Expired - Lifetime
- 2002-04-08 US US10/473,978 patent/US20050069535A1/en not_active Abandoned
- 2002-04-08 NZ NZ528598A patent/NZ528598A/en not_active IP Right Cessation
- 2002-04-08 JP JP2002579482A patent/JP2004528033A/en active Pending
- 2002-04-08 CZ CZ2003-2668A patent/CZ304424B6/en not_active IP Right Cessation
- 2002-04-08 AT AT02759751T patent/ATE406386T1/en active
- 2002-04-08 PT PT02759752T patent/PT1411064E/en unknown
- 2002-04-08 BR BR0208675-1A patent/BR0208675A/en not_active IP Right Cessation
- 2002-04-08 CZ CZ20032641A patent/CZ296276B6/en not_active IP Right Cessation
- 2002-04-08 BR BRPI0208676A patent/BR0208676B1/en not_active IP Right Cessation
- 2002-04-08 MX MXPA03008739A patent/MXPA03008739A/en active IP Right Grant
- 2002-04-08 SI SI200230766T patent/SI1384726T1/en unknown
- 2002-04-08 AU AU2002308348A patent/AU2002308348B2/en not_active Ceased
- 2002-04-08 CN CNB028084330A patent/CN1319991C/en not_active Expired - Fee Related
- 2002-04-08 ES ES02759751T patent/ES2312610T3/en not_active Expired - Lifetime
- 2002-04-08 HU HU0401695A patent/HU228105B1/en not_active IP Right Cessation
- 2002-04-08 EA EA200301097A patent/EA006936B1/en not_active IP Right Cessation
- 2002-04-08 AT AT02759752T patent/ATE378356T1/en active
- 2002-04-08 WO PCT/CU2002/000002 patent/WO2002081661A2/en active IP Right Grant
- 2002-04-08 SG SG200506530-5A patent/SG161737A1/en unknown
- 2002-04-08 EP EP02759752A patent/EP1411064B1/en not_active Expired - Lifetime
- 2002-04-08 AU AU2002308347A patent/AU2002308347B2/en not_active Ceased
- 2002-04-08 CA CA2443372A patent/CA2443372C/en not_active Expired - Fee Related
- 2002-04-08 CN CNB028086309A patent/CN100349920C/en not_active Expired - Fee Related
- 2002-04-08 PL PL02371770A patent/PL371770A1/en not_active Application Discontinuation
- 2002-04-08 DK DK02759751T patent/DK1384726T3/en active
- 2002-04-08 BR BRPI0208675-1A patent/BRPI0208675B1/en unknown
- 2002-04-08 DE DE60223547T patent/DE60223547T2/en not_active Expired - Lifetime
- 2002-04-08 DK DK02759752T patent/DK1411064T3/en active
- 2002-04-08 PE PE2002000283A patent/PE20020972A1/en not_active Application Discontinuation
- 2002-04-08 PL PL371937A patent/PL208109B1/en unknown
- 2002-04-08 CA CA2441845A patent/CA2441845C/en not_active Expired - Fee Related
- 2002-04-08 SI SI200230660T patent/SI1411064T1/en unknown
- 2002-04-08 EA EA200301098A patent/EA006310B1/en not_active IP Right Cessation
- 2002-04-08 US US10/473,977 patent/US20040253233A1/en not_active Abandoned
- 2002-04-08 EP EP02759751A patent/EP1384726B1/en not_active Expired - Lifetime
- 2002-08-04 UA UA2003108989A patent/UA75393C2/en unknown
- 2002-08-04 UA UA2003108988A patent/UA76745C2/en unknown
-
2003
- 2003-09-23 IS IS6964A patent/IS2701B/en unknown
- 2003-09-23 IS IS6965A patent/IS6965A/en unknown
- 2003-09-29 ZA ZA200307585A patent/ZA200307585B/en unknown
- 2003-09-30 EC EC2003004788A patent/ECSP034788A/en unknown
- 2003-09-30 EC EC2003004787A patent/ECSP034787A/en unknown
- 2003-10-01 ZA ZA2003/07679A patent/ZA200307679B/en unknown
- 2003-10-02 IL IL158246A patent/IL158246A/en not_active IP Right Cessation
- 2003-10-03 NO NO20034436A patent/NO331533B1/en not_active IP Right Cessation
- 2003-10-03 NO NO20034437A patent/NO20034437L/en not_active Application Discontinuation
- 2003-10-03 BG BG108227A patent/BG66293B1/en unknown
- 2003-10-03 BG BG108228A patent/BG66304B1/en unknown
- 2003-10-06 HR HR20030805A patent/HRP20030805B1/en not_active IP Right Cessation
- 2003-10-06 HR HR20030806A patent/HRP20030806B1/en not_active IP Right Cessation
-
2004
- 2004-12-14 HK HK04109894A patent/HK1066818A1/xx not_active IP Right Cessation
-
2005
- 2005-04-01 HK HK05102752A patent/HK1070080A1/en not_active IP Right Cessation
- 2005-12-20 UA UAA200512270A patent/UA86768C2/en unknown
-
2007
- 2007-10-26 AU AU2007231687A patent/AU2007231687B2/en not_active Expired - Fee Related
- 2007-12-31 HK HK07114311.6A patent/HK1109160A1/en not_active IP Right Cessation
-
2008
- 2008-08-07 KR KR1020087019420A patent/KR100919617B1/en not_active IP Right Cessation
-
2009
- 2009-03-19 US US12/407,046 patent/US8758753B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002308347A1 (en) | Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides | |
| HUP0401355A3 (en) | Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides | |
| IL251270A0 (en) | Cancer treatment | |
| HK1072443A1 (en) | Immunoconjugates for the treatment of tumours | |
| AU2002350235A1 (en) | Combination bacteriolytic therapy for the treatment of tumors | |
| IL164599A0 (en) | Combination therapy for the treatment of cancer | |
| HUP0400314A3 (en) | Pharmaceutical combinations for the treatment of cancer | |
| EP1599196A4 (en) | Combination therapies for the treatment of cancer | |
| HUP0500424A3 (en) | Combination therapy for the treatment of cancer | |
| AU2002334870B8 (en) | Combinations for the treatment of immunoinflammatory disorders | |
| HK1073244A1 (en) | Immunotherapeutic kit for the treatment of tumors | |
| AU2002221521A1 (en) | Immunotherapeutic combinations for the treatment of tumors | |
| AU2002304883A1 (en) | Device for the treatment of tumours | |
| AU2002351382A1 (en) | Combination cancer therapy | |
| AU2002346661A1 (en) | Photodynamic therapy for the treatment of epilepsy | |
| ZA200408071B (en) | Combination therapy for the treatment of cancer. | |
| GB0115870D0 (en) | Tumour therapy | |
| AU2001273081A1 (en) | Peptide combination for the treatment of cancer | |
| GB0118057D0 (en) | The cancer medicine invention | |
| ZA200306403B (en) | Cancer treatment. | |
| AU2002310189A1 (en) | Tumor therapy |